OpenAI AI Agent Swarm Behind Hugging Face Hack 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
Honda, Nissan Eye Shared Vehicle Software Platform by 2029 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Street Poller Media and The Boom of the Street Interview Ad Industry 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14% 
Mercer International Stock Surges 45% on C$20 Million Canada Funding 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Yindjibarndi Appeals Fortescue Mining Compensation Ruling 
Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
Google Changes EU Spam Policy Amid Antitrust Scrutiny 
Amazon Secures 200 MW Wind Power Deals in Sweden 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
Toyota Global Sales Fall as China Demand Slumps 
Add as a preferred source on Google
Press release - No. 10 / 2018
Zealand Pharma will attend the Kempen Life Science Conference on April 18, 2018 in Amsterdam
Copenhagen, April 12, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will attend the Kempen Life Science Conference in Amsterdam on April 18, 2018.
For further information, please contact:
Britt Meelby Jensen, President and Chief Executive Officer
Tel: +45 51 67 61 28, e-mail: [email protected]
Mats Blom, Senior Vice President, Chief Financial Officer
Tel: +45 31 53 79 73, e-mail: [email protected]
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim, and a pipeline of internal product candidates focusing on specialty gastrointestinal and metabolic diseases.
Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please visit www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.
Attachment
